Femasys (FEMY) EBT (2020 - 2026)

Femasys (FEMY) has reported EBT for 7 consecutive years, with -$4.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 2.57% year-over-year to -$4.5 million; the trailing twelve-month figure through Jun 2026 stood at -$20.1 million (up 4.47% YoY), and the FY2025 full-year result was -$18.6 million, up 0.96% from the prior year.
• EBT grew to -$4.5 million in Q2 2026 per FEMY's latest filing, from -$4.6 million in the prior quarter.
• Across five years, EBT topped out at -$2.6 million in Q2 2022 and bottomed at -$5.9 million in Q1 2025.
• Historically, EBT has averaged -$4.0 million across 5 years, with a median of -$4.0 million in 2023.
• The sharpest annual moves came in 2022 and 2026: EBT plunged 143.21% in 2022, then grew 2.57% in 2026.
• Over 5 years, EBT stood at -$2.9 million in 2022, then slumped by 52.69% to -$4.4 million in 2023, then slipped by 16.05% to -$5.1 million in 2024, then advanced by 10.32% to -$4.6 million in 2025, then grew by 2.57% to -$4.5 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$4.5 million, -$4.6 million, and -$5.9 million for Q2 2026, Q2 2025, and Q1 2025 respectively.